Tranexamic acid reduces blood loss after primary shoulder arthroplasty: a double-blind, placebo-controlled, prospective, randomized controlled trial

BACKGROUND: Tranexamic acid (TXA) is an antifibrinolytic that has been shown to decrease blood loss and transfusion rates after hip and knee arthroplasty, with only limited evidence to support its use in shoulder arthroplasty. This study was conducted to determine whether intravenous (IV) TXA is mor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JSES Open Access
Main Authors: Cvetanovich, Gregory L., Fillingham, Yale A., O'Brien, Michael, Forsythe, Brian, Cole, Brian J., Verma, Nikhil N., Romeo, Anthony A., Nicholson, Gregory P.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6334853/
https://ncbi.nlm.nih.gov/pubmed/30675563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jses.2018.01.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados